Abstract
A critical step in the pathogenesis of Toxoplasma gondii is conversion from the fast-replicating tachyzoite form experienced during acute infection to the slow-replicating bradyzoite form that establishes long-lived tissue cysts during chronic infection. Bradyzoite cyst development exhibits a clear tissue tropism in vivo, yet conditions of the host cell environment that influence this tropism remain unclear. Using an in vitro assay of bradyzoite conversion, we have found that cell types differ dramatically in the ability to facilitate differentiation of tachyzoites into bradyzoites. Characterization of cell types that were either resistant or permissive for conversion revealed that resistant cell lines release low molecular weight metabolites that could support tachyzoite growth under metabolic stress conditions and thereby inhibit bradyzoite formation in permissive cells. Biochemical analysis revealed that the glycolytic metabolite lactate is an inhibitory component of supernatants from resistant cells. Furthermore, upregulation of glycolysis in permissive cells through the addition of glucose or by overexpression of the host kinase, Akt, was sufficient to convert cells from a permissive to a resistant phenotype. These results suggest that the metabolic state of the host cell may play a role in determining the predilection of the parasite to switch from the tachyzoite to bradyzoite form.
| Original language | English |
|---|---|
| Pages (from-to) | 947-959 |
| Number of pages | 13 |
| Journal | International Journal for Parasitology |
| Volume | 42 |
| Issue number | 10 |
| DOIs | |
| State | Published - Sep 2012 |
Bibliographical note
Funding Information:This work was supported by NIH Grant R01AI057532 . We thank David Roos and Florence Dzierszinski (University of Pennsylvania, Philadelphia, Pennsylvania, USA) for generous gifts of Pru T.gondii reporter strains, Mark Schlissel (University of California, Berkeley, Berkeley, CA USA) for the myrAKT cDNA and Akt VIII inhibitor, and Ellen Robey (University of California, Berkeley) for comments on the manuscript.
Funding
This work was supported by NIH Grant R01AI057532 . We thank David Roos and Florence Dzierszinski (University of Pennsylvania, Philadelphia, Pennsylvania, USA) for generous gifts of Pru T.gondii reporter strains, Mark Schlissel (University of California, Berkeley, Berkeley, CA USA) for the myrAKT cDNA and Akt VIII inhibitor, and Ellen Robey (University of California, Berkeley) for comments on the manuscript.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute of Allergy and Infectious F32-AI286447 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI168214 Jason W. Rosch Diseases National Institute of Allergy and Infectious P30 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R00-AI166116 Christopher D. Radka Diseases National Institute of Allergy and Infectious T32-AI106700 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI192221 Jason W. Rosch Diseases National Inst... | R01AI057532 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Akt
- Bradyzoite differentiation
- Glycolysis
- Metabolism
- Toxoplasma gondii
ASJC Scopus subject areas
- Parasitology
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Host metabolism regulates growth and differentiation of Toxoplasma gondii'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver